In addition, we provide the first epidemiological evidence in Chinese pediatric population that L/A ratio was a potential better biomarker for diagnosis of MS than leptin or adiponectin alone, and the cut-off values of L/A varied by different gender and puberty. This evidence concerns the gene ADIPOQ and myeloid sarcoma.